My Profile
Edit Profile
My Follows
My Wires
My Drafts
Analytics
Email Preferences
Sign Out
home
Latest
Shares
ETFs
Markets
Livewire Live
Buy Hold Sell
Topics
Alternatives
Exchange Traded Funds (ETFs)
Growth
Income
Markets
Property
Retirement
Shares
Wealth
Shows
Buy Hold Sell
Expert Insights
Fund in Focus
Rapid Fire
Success and More Interesting Stuff
The Rules of Investing
Series
Listed Series
Livewire Live
Meet The Investor
Outlook Series
Reporting Season
Contributors
Find Funds
Newsletter
About Livewire
Advertising
Careers
Contact Us
Write a Wire
Notifications
Loading...
Write a wire
Account
My profile
My follows
My wires
My drafts
Analytics
Email preferences
Company
About Livewire
Advertising
Contact us
Sign out
Sign In
Join Free
Latest
Shares
ETFs
Markets
Livewire Live
Buy Hold Sell
Find funds
Newsletter
Topics
Alternatives
Exchange Traded Funds (ETFs)
Growth
Income
Markets
Property
Retirement
Shares
Wealth
Shows
Buy Hold Sell
Expert Insights
Fund in Focus
Rapid Fire
Success and More Interesting Stuff
The Rules of Investing
Series
Listed Series
Livewire Live
Meet The Investor
Outlook Series
Reporting Season
Categories
Asset Allocation
Commodities
Daily Report
Education
Equities
Fixed Income
Funds
Investment Theme
Macro
Private Markets
Property
Weekend Report
Find Funds
Contributors
Newsletter
About Livewire
Advertising
Careers
Contact Us
Market Wraps
Benitec Biopharma
Latest news and analysis on Benitec Biopharma
November 10, 2017 14:33
A new solution for doctors and painkillers
John Kimber
International Investment Research LLC
November 10, 2017 14:33
November 30, 2016 14:28
Executive Series - Benitec Biopharma (BLT) CEO, Greg West
BLT
BENITEC BIOPHARMA LIMITED
ASX:BLT
Followed by
15
people
BLT
BENITEC BIOPHARMA LIMITED
ASX:BLT
Followed by
15
people
CommSec
Online Stockbroker
November 30, 2016 14:28
2
most
popular
Shares
5 low-P/E stocks brokers think are buys
Sara Allen,
Livewire Markets
Buy Hold Sell
Buy Hold Sell: 6 ASX small caps thriving in a macro
storm
Anna Dadic,
Livewire Markets
Shares
The ASX stocks most exposed to the next leg higher in rates
Chris Conway,
Livewire Markets
Growth
Why young Australians should abandon the ASX
Tom Stelzer,
Livewire Markets
view all
Advertisement